within Pharmacolibrary.Drugs.ATC.S;

model S01BC01_1
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 1.6666666666666668e-07,
    adminDuration  = 600,
    adminMass      = 0.1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S01BC01_1</td></tr><td>route:</td><td>ophthalmic</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Indometacin (also known as indomethacin) is a non-steroidal anti-inflammatory drug (NSAID) used primarily to reduce fever, pain, stiffness, and swelling from inflammation. It is used to treat conditions such as rheumatoid arthritis, osteoarthritis, gout, and ankylosing spondylitis, as well as certain ophthalmic indications. The drug is approved and currently used in various oral and ophthalmic formulations.</p><h4>Pharmacokinetics</h4><p>PK parameters for ophthalmic topical administration in healthy adult volunteers (ocular tissues, limited systemic absorption).</p><h4>References</h4><ol><li><p>McCormack, PL (2011). Ketorolac 0.45% ophthalmic solution. <i>Drugs &amp; aging</i> 28(7) 583–589. DOI:<a href=\"https://doi.org/10.2165/11207450-000000000-00000\">10.2165/11207450-000000000-00000</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21721602/\">https://pubmed.ncbi.nlm.nih.gov/21721602</a></p></li><li><p>Nagai, N (2021). [Ocular Drug Delivery System-based on Solid Nanoparticles]. <i>Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan</i> 141(1) 47–53. DOI:<a href=\"https://doi.org/10.1248/yakushi.20-00177-3\">10.1248/yakushi.20-00177-3</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33390447/\">https://pubmed.ncbi.nlm.nih.gov/33390447</a></p></li><li><p>Sinha, VR, et al., &amp; Singh, G (2009). Ketorolac tromethamine formulations: an overview. <i>Expert opinion on drug delivery</i> 6(9) 961–975. DOI:<a href=\"https://doi.org/10.1517/17425240903116006\">10.1517/17425240903116006</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/19663721/\">https://pubmed.ncbi.nlm.nih.gov/19663721</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S01BC01_1;
